JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M411080200 on December 16, 2004

J. Biol. Chem., Vol. 280, Issue 10, 8742-8747, March 11, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/10/8742    most recent
M411080200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, L.
Right arrow Articles by Cohen, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, L.
Right arrow Articles by Cohen, J. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Expression of ABCG5 and ABCG8 Is Required for Regulation of Biliary Cholesterol Secretion*

Liqing Yu{ddagger}§, Sarita Gupta{ddagger}, Fang Xu¶, Amy D. B. Liverman||, Antonio Moschetta||, David J. Mangelsdorf||**, Joyce J. Repa{ddagger}{ddagger}§§, Helen H. Hobbs{ddagger}§**{ddagger}{ddagger}, and Jonathan C. Cohen{ddagger}{ddagger}{ddagger}¶¶

From the {ddagger}McDermott Center for Human Growth and Development, Departments of §Molecular Genetics, ||Pharmacology, {ddagger}{ddagger}Internal Medicine, and §§Physiology, Center for Human Nutrition, and **Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9046

The major pathway for elimination of cholesterol in mammals is via secretion into bile. Biliary cholesterol secretion is mediated by the ATP-binding cassette (ABC) transporters ABCG5 (G5) and ABCG8 (G8) and is stimulated by cholesterol and by the non-cholesterol steroids cholate and diosgenin. To define the relationship between G5G8 expression and biliary cholesterol secretion, we measured G5 and G8 mRNA levels and biliary cholesterol concentrations in genetically manipulated mice expressing 0, 1, 2, 5, 10, or 16 copies of the two genes. Biliary cholesterol levels varied directly with G5G8 copy number and hepatic mRNA levels over a >16-fold range. Thus neither delivery of cholesterol to the transporter nor levels of cholesterol acceptors in bile were limiting under these conditions. In wild-type mice, cholate and diosgenin both increased biliary cholesterol concentrations 2–3-fold. The increase in biliary cholesterol content was dependent on expression of G5 and G8; neither steroid increased biliary cholesterol levels in G5G8–/– mice. Cholate treatment was associated with a farnesoid X receptor (FXR)-dependent increase in hepatic mRNA and protein levels of G5 and G8. In contrast to cholate, diosgenin treatment did not affect G5G8 expression. Diosgenin increased the expression of several pregnane X receptor (PXR) target genes and the choleretic effect of diosgenin was reduced by ~70% in PXR knock-out mice. Thus G5 and G8 are required to modulate biliary cholesterol secretion in response to cholate and diosgenin, but the choleretic effects of these two steroids are mediated by different mechanisms requiring FXR and PXR, respectively.


Received for publication, September 27, 2004 , and in revised form, November 24, 2004.

* This work was supported by National Institutes of Health Grants HL20948 and HL72304, the Perot Family Foundation, the W. M. Keck Foundation, and the Donald W. Reynolds Clinical Cardiovascular Research Center at Dallas. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¶¶ To whom correspondence should be addressed: Center for Human Nutrition, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9052. Tel.: 214-648-4774; Fax: 214-648-4837; E-mail: jonathan.cohen{at}utsouthwestern.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
L. Calpe-Berdiel, N. Rotllan, C. Fievet, R. Roig, F. Blanco-Vaca, and J. C. Escola-Gil
Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8
J. Lipid Res., September 1, 2008; 49(9): 1904 - 1911.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
S Kidambi and S B Patel
Sitosterolaemia: pathophysiology, clinical presentation and laboratory diagnosis
J. Clin. Pathol., May 1, 2008; 61(5): 588 - 594.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
Z.-Y. Jiang, P. Parini, G. Eggertsen, M. A. Davis, H. Hu, G.-J. Suo, S.-D. Zhang, L. L. Rudel, T.-Q. Han, and C. Einarsson
Increased expression of LXR{alpha}, ABCG5, ABCG8, and SR-BI in the liver from normolipidemic, nonobese Chinese gallstone patients
J. Lipid Res., February 1, 2008; 49(2): 464 - 472.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. S. Sabeva, E. J. Rouse, and G. A. Graf
Defects in the Leptin Axis Reduce Abundance of the ABCG5-ABCG8 Sterol Transporter in Liver
J. Biol. Chem., August 3, 2007; 282(31): 22397 - 22405.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Yamamoto, H. Shimano, N. Inoue, Y. Nakagawa, T. Matsuzaka, A. Takahashi, N. Yahagi, H. Sone, H. Suzuki, H. Toyoshima, et al.
Protein Kinase A Suppresses Sterol Regulatory Element-binding Protein-1C Expression via Phosphorylation of Liver X Receptor in the Liver
J. Biol. Chem., April 20, 2007; 282(16): 11687 - 11695.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Hu, M. Chouinard, A. L. Cox, P. Sipes, M. Marcelo, J. Ficorilli, S. Li, H. Gao, T. P. Ryan, M. D. Michael, et al.
Farnesoid X Receptor Agonist Reduces Serum Asymmetric Dimethylarginine Levels through Hepatic Dimethylarginine Dimethylaminohydrolase-1 Gene Regulation
J. Biol. Chem., December 29, 2006; 281(52): 39831 - 39838.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. F. Oram and A. M. Vaughan
ATP-Binding Cassette Cholesterol Transporters and Cardiovascular Disease
Circ. Res., November 10, 2006; 99(10): 1031 - 1043.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
B. Sarkadi, L. Homolya, G. Szakacs, and A. Varadi
Human Multidrug Resistance ABCB and ABCG Transporters: Participation in a Chemoimmunity Defense System.
Physiol Rev, October 1, 2006; 86(4): 1179 - 1236.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
E. Ikonen
Mechanisms for cellular cholesterol transport: defects and human disease.
Physiol Rev, October 1, 2006; 86(4): 1237 - 1261.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. Kosters, C. Kunne, N. Looije, S. B. Patel, R. P. J. Oude Elferink, and A. K. Groen
The mechanism of ABCG5/ABCG8 in biliary cholesterol secretion in mice
J. Lipid Res., September 1, 2006; 47(9): 1959 - 1966.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
T. Plosch, J. N. van der Veen, R. Havinga, N. C. A. Huijkman, V. W. Bloks, and F. Kuipers
Abcg5/Abcg8-independent pathways contribute to hepatobiliary cholesterol secretion in mice
Am J Physiol Gastrointest Liver Physiol, September 1, 2006; 291(3): G414 - G423.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S.-P. Tam, L. Mok, G. Chimini, M. Vasa, and R. G. Deeley
ABCA1 mediates high-affinity uptake of 25-hydroxycholesterol by membrane vesicles and rapid efflux of oxysterol by intact cells
Am J Physiol Cell Physiol, September 1, 2006; 291(3): C490 - C502.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Stedman, C. Liddle, S. Coulter, J. Sonoda, J. G. Alvarez, R. M. Evans, and M. Downes
Benefit of farnesoid X receptor inhibition in obstructive cholestasis
PNAS, July 25, 2006; 103(30): 11323 - 11328.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
G. C. Ness, R. C. Holland, and D. Lopez
Selective Compensatory Induction of Hepatic HMG-CoA Reductase in Response to Inhibition of Cholesterol Absorption.
Experimental Biology and Medicine, May 1, 2006; 231(5): 559 - 565.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Bilz, V. Samuel, K. Morino, D. Savage, C. S. Choi, and G. I. Shulman
Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters
Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E716 - E722.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. Wang, C. Einarsson, C. Murphy, P. Parini, I. Bjorkhem, M. Gafvels, and G. Eggertsen
Studies on LXR- and FXR-mediated effects on cholesterol homeostasis in normal and cholic acid-depleted mice
J. Lipid Res., February 1, 2006; 47(2): 421 - 430.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. Moschetta, F. Xu, L. R. Hagey, G. P. van Berge-Henegouwen, K. J. van Erpecum, J. F. Brouwers, J. C. Cohen, M. Bierman, H. H. Hobbs, J. H. Steinbach, et al.
A phylogenetic survey of biliary lipids in vertebrates,
J. Lipid Res., October 1, 2005; 46(10): 2221 - 2232.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.